Calls for UK inquiry into sodium valproate epilepsy drug

There are calls for a UK inquiry into the sodium valproate epilepsy drug that has been linked to birth defects and developmental issues in children.

It’s also understood that UK health professionals were warned about the dangers of people using sodium valproate epilepsy drugs, but little seems to have been done – especially in the past – to ensure users were informed of the risks and were able to make decisions as to the use of the drug.

There are also questions over whether the drug should be classed as safe at all, and the HSE is reportedly looking at the issue. We may see a UK inquiry into the side-effects soon.

There is already a huge class action in France over the use of sodium valproate epilepsy drugs against Sanofi. Our Group Action Lawyers have been tracking progress and are keeping an eye on the news as we remain vigilant over any potential UK class action cases that we may need to initiate. It’s clear to us that greater warnings have been needed for women using the drug before or during pregnancy given the links to the birth defects and developmental issue.

Our experience with medical group action cases

Helping people claim in a class action case for medical negligence and medical product liability is one of our specialities. With a long history of representing large groups of individuals suffering because of a medical issue or medical product defect, we will be looking to take action for people and families who may be affected by the use of sodium valproate epilepsy drugs here in the UK.

If you would like to share you story with us, we will look to advise you as best as we can, and where we feel there is a potential claim to initiate, we can help you.

The developmental and infant deformities that have been reported as potentially linked to the use of sodium valproate epilepsy drugs lead to lifelong and serious suffering for the victims and their families. No one should ever suffer in silence: please don’t hesitate to contact us for help.